Summary

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Hematological Oncology Testing market size will reach Million USD in 2026 and is projected to reach Million USD by 2033, with a CAGR of % (2026-2033). Notably, the China Hematological Oncology Testing market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Hematological oncology testing encompasses a range of diagnostic and laboratory procedures designed to detect, characterize, and monitor blood-related cancers, including leukemia, lymphoma, and myeloma. These tests may involve analyzing blood samples, bone marrow aspirates, or lymph node biopsies to identify abnormal cells, assess genetic or molecular abnormalities, and determine the specific subtype and stage of the hematological malignancy. Common diagnostic tools include complete blood counts (CBC), flow cytometry, cytogenetic analysis, and molecular testing. Hematological oncology testing is crucial for accurate disease diagnosis, prognosis prediction, and treatment planning. It allows oncologists and hematologists to tailor therapeutic approaches, including chemotherapy, immunotherapy, and stem cell transplantation, based on the specific characteristics of the cancer, contributing to more effective and personalized management of hematological malignancies.

The major global suppliers of Hematological Oncology Testing include Bristol-Myers Squibb, Berry Genomics, Burnstone Biotechnology, BGI Genomics, Genetronhealth, HaploX, Amoy Diagnostics, GenoSaber Biotech, YZYBIO, Guangzhou Wondfo Biotech, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Hematological Oncology Testing. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Hematological Oncology Testing market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Hematological Oncology Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hematological Oncology Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Hematological Oncology Testing Include:

Bristol-Myers Squibb

Berry Genomics

Burnstone Biotechnology

BGI Genomics

Genetronhealth

HaploX

Amoy Diagnostics

GenoSaber Biotech

YZYBIO

Guangzhou Wondfo Biotech

Hematological Oncology Testing Product Segment Include:

ctDNA Testing

CTC Testing

Others

Hematological Oncology Testing Product Application Include:

Leukemia

Lymphoma

Multiple Myeloma




Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Hematological Oncology Testing Industry PESTEL Analysis

Chapter 3: Global Hematological Oncology Testing Industry Porter’s Five Forces Analysis

Chapter 4: Global Hematological Oncology Testing Major Regional Market Size and Forecast Analysis

Chapter 5: Global Hematological Oncology Testing Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Hematological Oncology Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Hematological Oncology Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Hematological Oncology Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Hematological Oncology Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Hematological Oncology Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Hematological Oncology Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Hematological Oncology Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

ページTOPに戻る

Table of Contents

Table of Contents

1 Hematological Oncology Testing Market Overview

  1.1 Product Definition and Statistical Scope

   1.2 Hematological Oncology Testing Product by Type

       1.2.1 ctDNA Testing

       1.2.2 CTC Testing

       1.2.3 Others

   1.3 Hematological Oncology Testing Product by Application

       1.3.1 Leukemia

       1.3.2 Lymphoma

       1.3.3 Multiple Myeloma

   1.4 Global Hematological Oncology Testing Market Size Analysis (2021-2033)

   1.5 Hematological Oncology Testing Market Development Status and Trends

       1.5.1 Hematological Oncology Testing Industry Development Status Analysis

       1.5.2 Hematological Oncology Testing Industry Development Trends Analysis

2 Hematological Oncology Testing Market PESTEL Analysis

   2.1 Political Factors Analysis

   2.2 Economic Factors Analysis

   2.3 Social Factors Analysis

   2.4 Technological Factors Analysis

   2.5 Environmental Factors Analysis

   2.6 Legal Factors Analysis

3 Hematological Oncology Testing Market Porter's Five Forces Analysis

   3.1 Competitive Rivalry

   3.2 Threat of New Entrants

   3.3 Bargaining Power of Suppliers

   3.4 Bargaining Power of Buyers

   3.5 Threat of Substitutes

4 Global Hematological Oncology Testing Market Analysis by Regions

   4.1 Hematological Oncology Testing Overall Market: 2025 VS 2026 VS 2033

   4.2 Global Hematological Oncology Testing Revenue and Forecast Analysis (2021-2033)

       4.2.1 Global Hematological Oncology Testing Revenue and Market Share by Region (2021-2026)

       4.2.2 Global Hematological Oncology Testing Revenue and Market Share Forecast by Region (2027-2033)

5 Global Hematological Oncology Testing Market Size by Type and Application

   5.1 Global Hematological Oncology Testing Market Size by Type (2021-2033)

   5.2 Global Hematological Oncology Testing Market Size by Application (2021-2033)

6 North America

   6.1 North America Hematological Oncology Testing Market Size and Growth Rate Analysis (2021-2033)

   6.2 North America Key Suppliers Analysis

   6.3 North America Hematological Oncology Testing Market Size by Type

   6.4 North America Hematological Oncology Testing Market Size by Application

   6.5 North America Hematological Oncology Testing Market Size by Country

       6.5.1 US

       6.5.2 Canada

7 Europe

   7.1 Europe Hematological Oncology Testing Market Size and Growth Rate Analysis (2021-2033)

   7.2 Europe Key Suppliers Analysis

   7.3 Europe Hematological Oncology Testing Market Size by Type

   7.4 Europe Hematological Oncology Testing Market Size by Application

   7.5 Europe Hematological Oncology Testing Market Size by Country

       7.5.1 Germany

       7.5.2 France

       7.5.3 United Kingdom

       7.5.4 Italy

       7.5.5 Spain

       7.5.6 Benelux

8 China

   8.1 China Hematological Oncology Testing Market Size and Growth Rate Analysis (2021-2033)

   8.2 China Key Suppliers Analysis

   8.3 China Hematological Oncology Testing Market Size by Type

   8.4 China Hematological Oncology Testing Market Size by Application

9 APAC (excl. China)

   9.1 APAC (excl. China) Hematological Oncology Testing Market Size and Growth Rate Analysis (2021-2033)

   9.2 APAC (excl. China) Key Suppliers Analysis

   9.3 APAC (excl. China) Hematological Oncology Testing Market Size by Type

   9.4 APAC (excl. China) Hematological Oncology Testing Market Size by Application

   9.5 APAC (excl. China) Hematological Oncology Testing Market Size by Country

       9.5.1 Japan

       9.5.2 South Korea

       9.5.3 India

       9.5.4 Australia

       9.5.5 Southeast Asia

10 Latin America

   10.1 Latin America Hematological Oncology Testing Market Size and Growth Rate Analysis (2021-2033)

   10.2 Latin America Key Suppliers Analysis

   10.3 Latin America Hematological Oncology Testing Market Size by Type

   10.4 Latin America Hematological Oncology Testing Market Size by Application

   10.5 Latin America Hematological Oncology Testing Market Size by Country

       10.5.1 Mexico

       10.5.2 Brazil

11 Middle East & Africa

   11.1 Middle East & Africa Hematological Oncology Testing Market Size and Growth Rate Analysis (2021-2033)

   11.2 Middle East & Africa Key Suppliers Analysis

   11.3 Middle East & Africa Hematological Oncology Testing Market Size by Type

   11.4 Middle East & Africa Hematological Oncology Testing Market Size by Application

   11.5 Middle East & Africa Hematological Oncology Testing Market Size by Country

       11.5.1 Saudi Arabia

       11.5.2 South Africa

12 Competition by Suppliers

   12.1 Global Hematological Oncology Testing Market Revenue by Key Suppliers (2021-2033)

   12.2 Hematological Oncology Testing Competitive Landscape Analysis and Market Dynamic

       12.2.1 Hematological Oncology Testing Competitive Landscape Analysis

       12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales

       12.2.3 Market Dynamic

13 Key Companies Analysis

   13.1 Bristol-Myers Squibb

       13.1.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.1.2 Bristol-Myers Squibb Hematological Oncology Testing Product Portfolio

       13.1.3 Bristol-Myers Squibb Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.2 Berry Genomics

       13.2.1 Berry Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.2.2 Berry Genomics Hematological Oncology Testing Product Portfolio

       13.2.3 Berry Genomics Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.3 Burnstone Biotechnology

       13.3.1 Burnstone Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.3.2 Burnstone Biotechnology Hematological Oncology Testing Product Portfolio

       13.3.3 Burnstone Biotechnology Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.4 BGI Genomics

       13.4.1 BGI Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.4.2 BGI Genomics Hematological Oncology Testing Product Portfolio

       13.4.3 BGI Genomics Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.5 Genetronhealth

       13.5.1 Genetronhealth Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.5.2 Genetronhealth Hematological Oncology Testing Product Portfolio

       13.5.3 Genetronhealth Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.6 HaploX

       13.6.1 HaploX Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.6.2 HaploX Hematological Oncology Testing Product Portfolio

       13.6.3 HaploX Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.7 Amoy Diagnostics

       13.7.1 Amoy Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.7.2 Amoy Diagnostics Hematological Oncology Testing Product Portfolio

       13.7.3 Amoy Diagnostics Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.8 GenoSaber Biotech

       13.8.1 GenoSaber Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.8.2 GenoSaber Biotech Hematological Oncology Testing Product Portfolio

       13.8.3 GenoSaber Biotech Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.9 YZYBIO

       13.9.1 YZYBIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.9.2 YZYBIO Hematological Oncology Testing Product Portfolio

       13.9.3 YZYBIO Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.10 Guangzhou Wondfo Biotech

       13.10.1 Guangzhou Wondfo Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.10.2 Guangzhou Wondfo Biotech Hematological Oncology Testing Product Portfolio

       13.10.3 Guangzhou Wondfo Biotech Hematological Oncology Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

   14.1 Hematological Oncology Testing Industry Chain Analysis

   14.2 Hematological Oncology Testing Typical Downstream Customers

   14.3 Hematological Oncology Testing Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

   16.1 Methodology/Research Approach

   16.2 Research Scope

   16.3 Benchmarks and Assumptions

   16.4 Date Source

       16.4.1 Primary Sources

       16.4.2 Secondary Sources

   16.5 Data Cross Validation

   16.6 Disclaimer